TCCM
AZN icon

Timber Creek Capital Management’s AstraZeneca AZN Stock Holding History

Timber Creek Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,708
Closed -$5.65M – 80
2025
Q4 		$5.65M Sell
30,708
-230
-0.7% -$40.3K 1.31% 29
2025
Q3 		$4.75M Sell
30,938
-144
-0.5% -$21.8K 1.15% 33
2025
Q2 		$4.63M Sell
31,082
-29
-0.1% -$4.06K 1.18% 32
2025
Q1 		$4.57M Sell
31,111
-27
-0.1% -$3.91K 1.22% 34
2024
Q4 		$4.08M Sell
31,138
-476
-2% -$66.6K 1.18% 34
2024
Q3 		$4.93M Buy
31,614
+227
+0.7% +$36.6K 1.38% 29
2024
Q2 		$4.9M Sell
31,387
-5,967
-16% -$898K 1.48% 27
2024
Q1 		$5.06M Sell
37,354
-3,005
-7% -$398K 1.58% 23
2023
Q4 		$5.44M Buy
40,359
+518
+1% +$67.3K 1.85% 18
2023
Q3 		$5.4M Sell
39,841
-675
-2% -$92.2K 1.95% 18
2023
Q2 		$5.8M Sell
40,516
-27
-0.1% -$3.97K 2% 17
2023
Q1 		$5.63M Sell
40,543
-47
-0.1% -$6.32K 2.01% 16
2022
Q4 		$5.5M Sell
40,590
-176
-0.4% -$22.1K 2.08% 16
2022
Q3 		$4.47M Sell
40,766
-1,688
-4% -$214K 1.77% 24
2022
Q2 		$5.61M Sell
42,454
-8,534
-17% -$1.12M 1.85% 20
2022
Q1 		$6.76M Buy
50,988
+5,099
+11% +$611K 2.05% 16
2021
Q4 		$5.35M Buy
45,889
+827
+2% +$97.3K 1.59% 28
2021
Q3 		$5.41M Buy
45,062
+159
+0.4% +$18.5K 1.72% 29
2021
Q2 		$5.38M Buy
44,903
+6,575
+17% +$721K 1.74% 29
2021
Q1 		$3.81M Buy
38,328
+2,583
+7% +$260K 1.47% 30
2020
Q4 		$3.57M Buy
35,745
+372
+1% +$39.4K 1.59% 25
2020
Q3 		$3.88M Buy
35,373
+225
+0.6% +$25K 2.13% 17
2020
Q2 		$3.72M Buy
35,148
+1,143
+3% +$118K 2.33% 17
2020
Q1 		$3.04M Buy
+34,005
New +$3.2M 2.22% 16

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Timber Creek Capital Management's AZN Position: Q1 2026 in Review

Timber Creek Capital Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 30,708 shares — an estimated $5.65M sold.

Timber Creek Capital Management first reported a position in AZN in Q1 2020 and held it in 24 quarters. The position peaked at $6.76M in Q1 2022. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Timber Creek Capital Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Timber Creek Capital Management sold 30,708 AstraZeneca shares in Q1 2026, an estimated $5.65M.
  • Timber Creek Capital Management first reported a position in AstraZeneca in Q1 2020 and held it in 24 quarters.
  • Timber Creek Capital Management's AstraZeneca position peaked at $6.76M in Q1 2022.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Timber Creek Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.